Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Twelve years experience with high-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's disease patients in first remission after MOPP/ABVD chemotherapy.
Carella AM, Prencipe E, Pungolino E, Lerma E, Frassoni F, Rossi E, Giordano D, Occhini D, Gatti AM, Bruni R, Spriano M, Nati S, Pierluigi D, Congiu M, Vimercati R, Ravetti JL, Federico M. Carella AM, et al. Among authors: vimercati r. Leuk Lymphoma. 1996 Mar;21(1-2):63-70. doi: 10.3109/10428199609067581. Leuk Lymphoma. 1996. PMID: 8907271 Clinical Trial.
High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
Carella AM, Chimirri F, Podestà M, Pitto A, Piaggio G, Dejana A, Lerma E, Pollicardo N, Vassallo F, Soracco M, Benvenuto F, Valbonesi M, Carlier P, Vimercati R, Prencipe E, Gatti AM, Ferrara RA, Incagliato M, Florio G, Frassoni F. Carella AM, et al. Among authors: vimercati r. Bone Marrow Transplant. 1996 Feb;17(2):201-5. Bone Marrow Transplant. 1996. PMID: 8640167 Clinical Trial.
Mobilization/transplantation of peripheral blood progenitor cells for aggressive non-Hodgkin's lymphoma with marrow involvement.
Santini G, Congiu AM, Nati S, Canepa L, Spriano M, Chisesi T, Rossi E, Vimercati R, Sertoli MR, Figari O, Gobbi M, Piaggio G, Vassallo F, Benvenuto F, Soracco M, Miglino M, Ravetti JL, Truini M. Santini G, et al. Among authors: vimercati r. Leuk Lymphoma. 1997 Dec;26 Suppl 1:83-8. doi: 10.3109/10428199709058604. Leuk Lymphoma. 1997. PMID: 9570684
High-dose cyclophosphamide followed by autografting can improve the outcome of relapsed or resistant non-Hodgkin's lymphomas with involved or hypoplastic bone marrow.
Santini G, De Souza C, Congiu AM, Nati S, Marino G, Soracco M, Sertoli MR, Rubagotti A, Spriano M, Vassallo F, Rossi E, Vimercati R, Piaggio G, Figari O, Benvenuto F, Abate M, Truini M, Ravetti JL, Ribizzi I, Damasio E. Santini G, et al. Among authors: vimercati r. Leuk Lymphoma. 1999 Apr;33(3-4):321-30. doi: 10.3109/10428199909058432. Leuk Lymphoma. 1999. PMID: 10221512 Clinical Trial.
Autologous Unpurged Bone Marrow Transplantation for Acute Non Lymphoblastic Leukemia in First Remission.
Carella AM, Nati S, Carlier P, Pierluigi D, Giordano D, Congiu A, Santini G, Scarpati D, Barra S, Corvo R, Vitale V, Raffo MR, Cerri R, Risso M, Spriano M, Vimercati R, Pungolino E, Bacigalupo A, Damasio E. Carella AM, et al. Among authors: vimercati r. Leuk Lymphoma. 1991;5(1):43-7. doi: 10.3109/10428199109068103. Leuk Lymphoma. 1991. PMID: 27463208
Fludarabine, cyclophosphamide and mitoxantrone for untreated follicular lymphoma: a report from the non-Hodgkin's lymphoma co-operative study group.
Santini G, Chisesi T, Nati S, Porcellini A, Zoli V, Rizzoli V, Zupo S, Marino G, Rubagotti A, Polacco A, Spriano M, Vimercati R, Congiu AM, Ravetti JL, Aversa S, Candela M, Patti C. Santini G, et al. Among authors: vimercati r. Leuk Lymphoma. 2004 Jun;45(6):1141-7. doi: 10.1080/10428190310001623874. Leuk Lymphoma. 2004. PMID: 15359993
VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
Santini G, Salvagno L, Leoni P, Chisesi T, De Souza C, Sertoli MR, Rubagotti A, Congiu AM, Centurioni R, Olivieri A, Tedeschi L, Vespignani M, Nati S, Soracco M, Porcellini A, Contu A, Guarnaccia C, Pescosta N, Majolino I, Spriano M, Vimercati R, Rossi E, Zambaldi G, Mangoni L, Rizzoli V, et al. Santini G, et al. Among authors: vimercati r. J Clin Oncol. 1998 Aug;16(8):2796-802. doi: 10.1200/JCO.1998.16.8.2796. J Clin Oncol. 1998. PMID: 9704732 Clinical Trial.
First line Fludarabine treatment of symptomatic chronic lymphoproliferative diseases: clinical results and molecular analysis of minimal residual disease.
Clavio M, Miglino M, Spriano M, Pietrasanta D, Vallebella E, Celesti L, Canepa L, Pierri I, Cavaliere M, Ballerini F, Beltrami G, Rossi E, Vimercati R, Bruni R, Congiu M, Nati S, Damasio E, Santini G, Gobbi M. Clavio M, et al. Among authors: vimercati r. Eur J Haematol. 1998 Sep;61(3):197-203. doi: 10.1111/j.1600-0609.1998.tb01084.x. Eur J Haematol. 1998. PMID: 9753416
39 results